Sanchez Machado, M.; Upadhyaya, S.A.; Gadiraju, S.; Santhosh, M.; Gaba, J.; Mcdonnell, P.J.; Hincapie-Echeverri, J.; Barrero, C.A.
Rational Immune Checkpoint Inhibitor-Based Combination Immunotherapy in Cancer: Mechanistic Design, Biomarker Selection, and Implications for Oncology Pharmacy. Cancers 2026, 18, 2163.
https://doi.org/10.3390/cancers18132163
AMA Style
Sanchez Machado M, Upadhyaya SA, Gadiraju S, Santhosh M, Gaba J, Mcdonnell PJ, Hincapie-Echeverri J, Barrero CA.
Rational Immune Checkpoint Inhibitor-Based Combination Immunotherapy in Cancer: Mechanistic Design, Biomarker Selection, and Implications for Oncology Pharmacy. Cancers. 2026; 18(13):2163.
https://doi.org/10.3390/cancers18132163
Chicago/Turabian Style
Sanchez Machado, Mathias, Sangnya A. Upadhyaya, Saipriya Gadiraju, Matthew Santhosh, John Gaba, Patrick J. Mcdonnell, Jacobo Hincapie-Echeverri, and Carlos A. Barrero.
2026. "Rational Immune Checkpoint Inhibitor-Based Combination Immunotherapy in Cancer: Mechanistic Design, Biomarker Selection, and Implications for Oncology Pharmacy" Cancers 18, no. 13: 2163.
https://doi.org/10.3390/cancers18132163
APA Style
Sanchez Machado, M., Upadhyaya, S. A., Gadiraju, S., Santhosh, M., Gaba, J., Mcdonnell, P. J., Hincapie-Echeverri, J., & Barrero, C. A.
(2026). Rational Immune Checkpoint Inhibitor-Based Combination Immunotherapy in Cancer: Mechanistic Design, Biomarker Selection, and Implications for Oncology Pharmacy. Cancers, 18(13), 2163.
https://doi.org/10.3390/cancers18132163
